Sunshine Biopharma (SBFM) Competitors $1.40 -0.02 (-1.41%) Closing price 08/22/2025 03:49 PM EasternExtended Trading$1.46 +0.07 (+4.64%) As of 08/22/2025 04:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SBFM vs. FBLG, RNTX, RVPH, RLYB, NAII, ASBP, NNVC, QTTB, PASG, and LSTAShould you be buying Sunshine Biopharma stock or one of its competitors? The main competitors of Sunshine Biopharma include FibroBiologics (FBLG), Rein Therapeutics (RNTX), Reviva Pharmaceuticals (RVPH), Rallybio (RLYB), Natural Alternatives International (NAII), Aspire Biopharma (ASBP), NanoViricides (NNVC), Q32 Bio (QTTB), Passage Bio (PASG), and Lisata Therapeutics (LSTA). These companies are all part of the "pharmaceutical products" industry. Sunshine Biopharma vs. Its Competitors FibroBiologics Rein Therapeutics Reviva Pharmaceuticals Rallybio Natural Alternatives International Aspire Biopharma NanoViricides Q32 Bio Passage Bio Lisata Therapeutics Sunshine Biopharma (NASDAQ:SBFM) and FibroBiologics (NASDAQ:FBLG) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, risk, earnings, analyst recommendations, valuation, media sentiment, institutional ownership and profitability. Is SBFM or FBLG more profitable? FibroBiologics has a net margin of 0.00% compared to Sunshine Biopharma's net margin of -17.35%. Sunshine Biopharma's return on equity of -26.04% beat FibroBiologics' return on equity.Company Net Margins Return on Equity Return on Assets Sunshine Biopharma-17.35% -26.04% -20.72% FibroBiologics N/A -710.25%-118.02% Do institutionals and insiders have more ownership in SBFM or FBLG? 42.0% of Sunshine Biopharma shares are held by institutional investors. 0.1% of Sunshine Biopharma shares are held by insiders. Comparatively, 20.0% of FibroBiologics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Does the media prefer SBFM or FBLG? In the previous week, FibroBiologics had 1 more articles in the media than Sunshine Biopharma. MarketBeat recorded 1 mentions for FibroBiologics and 0 mentions for Sunshine Biopharma. Sunshine Biopharma's average media sentiment score of 0.00 equaled FibroBiologics'average media sentiment score. Company Overall Sentiment Sunshine Biopharma Neutral FibroBiologics Neutral Do analysts rate SBFM or FBLG? Sunshine Biopharma presently has a consensus price target of $15.00, suggesting a potential upside of 971.43%. FibroBiologics has a consensus price target of $13.00, suggesting a potential upside of 2,108.63%. Given FibroBiologics' stronger consensus rating and higher probable upside, analysts clearly believe FibroBiologics is more favorable than Sunshine Biopharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sunshine Biopharma 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00FibroBiologics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20 Which has higher earnings & valuation, SBFM or FBLG? Sunshine Biopharma has higher revenue and earnings than FibroBiologics. FibroBiologics is trading at a lower price-to-earnings ratio than Sunshine Biopharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSunshine Biopharma$34.87M0.18-$5.13M-$150.88-0.01FibroBiologicsN/AN/A-$11.16M-$0.36-1.64 Which has more volatility & risk, SBFM or FBLG? Sunshine Biopharma has a beta of 1.45, indicating that its share price is 45% more volatile than the S&P 500. Comparatively, FibroBiologics has a beta of -0.74, indicating that its share price is 174% less volatile than the S&P 500. SummaryFibroBiologics beats Sunshine Biopharma on 8 of the 15 factors compared between the two stocks. Get Sunshine Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for SBFM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SBFM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SBFM vs. The Competition Export to ExcelMetricSunshine BiopharmaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.38M$3.12B$5.82B$9.78BDividend YieldN/A2.23%4.40%4.06%P/E Ratio-0.0121.0031.3026.05Price / Sales0.18356.92455.29117.98Price / CashN/A44.5038.0259.36Price / Book0.258.129.536.60Net Income-$5.13M-$54.72M$3.26B$265.65M7 Day Performance-6.03%2.62%2.13%1.99%1 Month Performance-9.68%3.25%3.21%0.45%1 Year Performance-54.10%10.82%30.18%18.87% Sunshine Biopharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SBFMSunshine Biopharma2.1214 of 5 stars$1.40-1.4%$15.00+971.4%-54.1%$6.38M$34.87M-0.013FBLGFibroBiologics2.7265 of 5 stars$0.60-2.9%$13.00+2,070.3%-62.7%$25.47MN/A-1.6910Short Interest ↑RNTXRein TherapeuticsN/A$1.10-2.7%N/AN/A$25.36MN/A-0.419News CoverageAnalyst DowngradeRVPHReviva Pharmaceuticals2.6958 of 5 stars$0.52+0.5%$7.17+1,272.9%-44.4%$25.06MN/A-0.805News CoverageAnalyst RevisionRLYBRallybio3.0785 of 5 stars$0.60-4.4%$10.00+1,575.0%-44.6%$24.95M$640K-0.6440Analyst UpgradeShort Interest ↓NAIINatural Alternatives InternationalN/A$3.90+1.7%N/A-23.9%$24.13M$113.80M-2.81290ASBPAspire BiopharmaN/A$0.49-17.6%N/AN/A$24.09MN/A0.00N/AGap DownNNVCNanoViricides0.7239 of 5 stars$1.49-2.9%N/A-23.2%$23.87MN/A-2.0620Gap UpQTTBQ32 Bio2.5583 of 5 stars$1.86-8.8%$12.17+554.1%-95.2%$22.69M$1.16M-0.4339News CoverageShort Interest ↓PASGPassage Bio3.7979 of 5 stars$7.11-1.6%$91.75+1,191.3%-49.9%$22.59MN/A-0.39130LSTALisata Therapeutics2.5412 of 5 stars$2.52+0.4%$23.50+832.5%-13.7%$22.39M$1M-1.1530Analyst ForecastAnalyst RevisionGap Down Related Companies and Tools Related Companies FBLG Competitors RNTX Competitors RVPH Competitors RLYB Competitors NAII Competitors ASBP Competitors NNVC Competitors QTTB Competitors PASG Competitors LSTA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SBFM) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersNations are at war over what’s in this boxA resource known as Element 29 is quickly becoming one of the most sought-after materials on the planet. Goldm...Behind the Markets | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredTrump’s “new dollar” could shock Americans"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.On a quiet Friday afternoon, one trader spotted an overlooked stock. He bought shares. He shut down his ...Timothy Sykes | SponsoredBREAKING: The House just passed 3 pro-crypto bills!The “top secret” DeFi play Our #1 Coin Report reveals which protocol is building this institutional bridge...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sunshine Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sunshine Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access